ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,689Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 670

$843K Total Retail Price of All Prescriptions

Rank: 59 out of 670

456 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 12,204 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 518 376 S3 1 1
FUROSEMIDE 513 476 2 6
ATORVASTATIN CALCIUM 451 352 3 15
LISINOPRIL 446 393 4 3
OMEPRAZOLE 405 329 5 5
LEVOTHYROXINE SODIUM 374 325 6 2
ATENOLOL 339 311 7 17
AMLODIPINE BESYLATE 299 272 8 7
LOVASTATIN 283 192 9 44
POTASSIUM CHLORIDE 267 247 10 16
WARFARIN SODIUM 233 217 11 13
SERTRALINE HCL 227 203 12 22
DIGOXIN 219 219 13 46
DONEPEZIL HCL 212 198 14 31
SIMVASTATIN 209 161 15 4
MIRTAZAPINE 189 176 16 59
METOPROLOL SUCCINATE 180 164 17 12
METFORMIN HCL 178 143 18 8
GABAPENTIN 170 149 19 11
GLIPIZIDE 169 160 20 67
OXYCODONE-ACETAMINOPHEN 163 121 S2 21 77
METOPROLOL TARTRATE 152 130 22 9
ZOLPIDEM TARTRATE 149 118 23 23
CITALOPRAM HBR 142 100 24 20
ALENDRONATE SODIUM 142 135 24 43
NAMENDA 134 130 26 54
MELOXICAM 129 121 27 33
CARVEDILOL 129 124 27 29
AZITHROMYCIN 121 102 29 35
VERAPAMIL ER 121 116 29 94
ALLOPURINOL 119 114 31 38
MORPHINE SULFATE ER 118 67 S2 32 104
FELODIPINE ER 113 94 33 144
ZETIA 107 82 34 66
POLYETHYLENE GLYCOL 3350 107 95 34 79
TRAMADOL HCL 105 83 36 21
PRAVASTATIN SODIUM 105 87 36 19
HYDROCHLOROTHIAZIDE 98 81 38 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 69 39 27
NEXIUM 96 65 40 14
RANITIDINE HCL 96 96 40 25
ESCITALOPRAM OXALATE 94 79 42 78
LACTULOSE 89 89 43 107
CRESTOR 88 74 44 18
FLUOXETINE HCL 86 64 45 55
ISOSORBIDE MONONITRATE ER 84 67 46 45
METHADONE HCL 84 47 S2 46 206
FENTANYL 83 82 S2 48 76
CIPROFLOXACIN HCL 77 66 49 60
TAMSULOSIN HCL 76 68 50 30
LOSARTAN-HYDROCHLOROTHIAZIDE 75 64 51 73
PROPRANOLOL HCL 72 68 52 130
TRAZODONE HCL 69 55 53 39
PROAIR HFA 68 46 54 28
AMLODIPINE BESYLATE-BENAZEPRIL 65 58 55 74
PREDNISONE 63 51 56 40
ACTOS 62 61 57 105
DEXILANT 62 43 57 70
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 52 59 93
NITROGLYCERIN PATCH 60 60 59 149
TRILIPIX 57 39 61 141
OXYCODONE HCL 56 26 S2 62 72
DILTIAZEM 24HR ER 56 49 62 122
DIOVAN 55 41 64 48
IPRATROPIUM-ALBUTEROL 54 49 65 136
QUETIAPINE FUMARATE 53 46 66 84
CELEBREX 52 48 67 89
METOLAZONE 51 33 68 227
LYRICA 51 21 68 65
CARBIDOPA-LEVODOPA 50 50 70 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.